Form 4: MeiraGTx CEO Sells 62,000 Shares Under 10b5-1 Plan

MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, sold 62,000 ordinary shares for a weighted average price of $7.41 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Alexandria Forbes, President & CEO, Director, and 10% Owner of MeiraGTx Holdings plc, disposed of 62,000 ordinary shares.
• The transaction occurred on March 24, 2026.
• The shares were sold at a weighted average price of $7.41 per share, with individual sales ranging from $7.27 to $7.56.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.
• Following this transaction, Forbes beneficially owns 1,449,695 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a pre-planned insider sale for personal financial management rather than a reaction to new company-specific news or performance.

Negatives

• The sale of 62,000 shares by a key executive, even under a pre-arranged plan, represents a reduction in direct beneficial ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even under Rule 10b5-1 plans, are common for executives managing personal finances and diversifying portfolios. In the biotechnology sector, such sales are typically viewed in the context of the company's clinical pipeline and regulatory milestones rather than as a direct indicator of operational performance.

Comparison to Industry Standards

• This transaction is a routine insider sale under a pre-arranged 10b5-1 plan, a common practice among executives in publicly traded companies across all sectors, including biotechnology. It does not directly compare to specific project results or financial performance benchmarks of other companies.

Related Party Transactions

• Sale of 62,000 ordinary shares by Alexandria Forbes, President & CEO, Director, and 10% Owner of MeiraGTx Holdings plc.

Stakeholder Impact

• Shareholders: May perceive insider selling, even planned, with caution, though the impact is likely minimal given the 10b5-1 plan.

Key Dates

Recommendation

The sale by CEO Alexandria Forbes was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned personal financial transaction rather than a reaction to new company developments. This type of routine insider activity generally does not provide a strong signal for a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

MeiraGTx Holdings plc, MGTX, Alexandria Forbes, Insider Sale, Form 4, 10b5-1 Plan, CEO Stock Sale, Biotechnology, Gene Therapy